PCCM Hub
Back to Library
ILD / DPLDCurrent Guideline Must Read⚡ High-Yield Board Topic

Diagnosis of Idiopathic Pulmonary Fibrosis: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Raghu G, Remy-Jardin M, Richeldi L et al.·American Journal of Respiratory and Critical Care Medicine·2022· DOI: 10.1164/rccm.202202-0399ST
IPFILDUIPHRCTDiagnosisATSERSGuidelines
AI

AI-Generated Summary

Educational summary — always verify with primary source
Background

IPF diagnosis requires integration of clinical, radiological (HRCT), and pathological data. The 2022 guideline updated the 2018 guideline with new evidence on HRCT patterns and BAL.

Study Design

ATS/ERS/JRS/ALAT evidence-based guideline using GRADE methodology.

Key Findings

Key updates: (1) Four HRCT UIP patterns: typical, probable, indeterminate, alternative diagnosis; (2) Typical UIP on HRCT in appropriate clinical context = IPF diagnosis without biopsy; (3) BAL lymphocytosis >40% suggests alternative diagnosis; (4) Genomic classifier (Envisia) conditionally recommended.

Clinical Bottom Line

Know the four HRCT UIP patterns and when biopsy is needed. Typical UIP (bilateral basal honeycombing ± traction bronchiectasis) in the right clinical context = IPF without biopsy. Probable UIP may require biopsy. Alternative diagnosis pattern = look for other ILD.

Limitations & Caveats

Guideline — some recommendations are conditional with low-quality evidence. Genomic classifier not universally available.

Read Full Article

Access the complete publication on PubMed

Open PubMed

Send Feedback

Help us improve PCCM Hub

What kind of feedback do you have?